Skip to content

Lonafarnib

Lonafarnib comes in 2 pill versions in our database, in 2 strengths, from 1 manufacturer. Check the imprint to tell them apart.

Lonafarnib pill images

50 mg 1 pill

75 mg 1 pill

What is Lonafarnib used for?

Lonafarnib is a farnesyltransferase inhibitor.

Medicine type
Farnesyltransferase inhibitor
Official uses from the US prescribing label

ZOKINVY is indicated in patients 12 months of age and older with a body surface area (BSA) of 0.39 m2 and above:

  • To reduce the risk of mortality in Hutchinson-Gilford Progeria Syndrome (HGPS)
  • For the treatment of processing-deficient Progeroid Laminopathies with either:
    • Heterozygous LMNA mutation with progerin-like protein accumulation
    • Homozygous or compound heterozygous ZMPSTE24 mutations

Limitations of Use

ZOKINVY is not indicated for other Progeroid Syndromes or processing-proficient Progeroid Laminopathies. Based upon its mechanism of action, ZOKINVY would not be expected to be effective in these populations.

From the FDA-approved label on DailyMed (published Jan 16, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.